Fosun Health Capital

Cellbri is a manufacturing company that produces and sells automated CGT industrial instruments for cell processing programs.

Celregen Therapeutics is a pharmaceutical company specializing in the development of innovative medicines in the fields of cell therapy and regenerative medicine. The company offers platform-based solutions, including rapid induced pluripotent stem cell (iPSC) reprogramming, a patented CRISPR/Cas12b-based iPSC gene-editing platform, and bioinformatics-guided differentiation techniques across various germ layers. These technologies cover comprehensive upstream and downstream research and development processes for iPSCs and their derivative products.

Transcend Vivoscope is a biotechnology company that focuses on the development of advanced microscopy imaging products and solutions. Its high-resolution imaging systems are designed to meet the needs of healthcare providers, enabling them to create innovative tools for various applications, including 3D cell biology, neuroscience, developmental biology, and clinical medicine. By offering cutting-edge technology, Transcend Vivoscope aims to enhance the capabilities of healthcare professionals in their research and clinical practices.

Aiyi Animal Medicine develops and produces veterinary biological products and veterinary chemical medications.

Jishi Medical is a med-tech company that specializes in the research and development of eye diseases and overall solutions for ophthalmology diagnosis and treatment.

Celregen Therapeutics is a pharmaceutical company specializing in the development of innovative medicines in the fields of cell therapy and regenerative medicine. The company offers platform-based solutions, including rapid induced pluripotent stem cell (iPSC) reprogramming, a patented CRISPR/Cas12b-based iPSC gene-editing platform, and bioinformatics-guided differentiation techniques across various germ layers. These technologies cover comprehensive upstream and downstream research and development processes for iPSCs and their derivative products.

Shengbao Bio is committed to the development of novel live bacterial medications, leveraging gene circuits and precise regulation of gene and payload expression.

Conjustar, a protein-conjugated medicine developer that has rapidly built a robust R&D pipeline through a combination of introduction and independent research and development. it delivers more effective and safer new cancer therapy options to the majority of cancer patients.

AIMIRA Innovation Technology is an AI-based medical technology company that offers diagnosis, aesthetic plastic surgery, and anti-aging medicine.

Atantares is a biotechnology company that leverages semiconductor technology to advance biomedicine through innovative microfluidics solutions. By utilizing the miniaturization and integration capabilities of silicon chips, the company develops precision medicines and smart diagnostic devices aimed at transforming disease management in hematology, cardiology, neurology, and oncology. Atantares offers a proprietary coagulation device designed to monitor specific drugs and blood products, employing coagulation assays that assess platelet function, clotting times, and viscoelasticity. Furthermore, the company focuses on creating a chimeric antigen receptor for the treatment of hematological tumors and various diseases, utilizing an ultrasensitive immunoassay platform to provide crucial cytokine profile data for the effective management of CAR T-cell therapy and cytokine release syndrome mitigation.

Boao Mingsai is a biopharmaceutical company that focuses on the drug development.

Conjustar, a protein-conjugated medicine developer that has rapidly built a robust R&D pipeline through a combination of introduction and independent research and development. it delivers more effective and safer new cancer therapy options to the majority of cancer patients.

Chaomu Technology is a high-tech research and development enterprise dedicated to solving difficult human eye diseases. The company provides medical intelligent high-tech equipment and solutions. The pursuit of super purpose is to alleviate the increasing sub-light suffering of eye disease patients worldwide in a more scientific manner and to realize the dream of returning hundreds of millions of eye disease patients to a bright world.

Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.

Boao Mingsai is a biopharmaceutical company that focuses on the drug development.